Year: 2019

Treating C. diff: new purpose for an old drug?

An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.

Drea Gaffney thinks of her own father every time she speaks with patients about their bills

Gaffney said that the best part of her job is being able to tell patients that their account is resolved, and they don’t have to worry about it any more.

Tailoring treatment for heart defect

By defining the clinical and genetic factors that predict treatment response, Vanderbilt investigators aim to personalize therapy for a common heart complication in preterm infants.

array of test tubes with pipette dropping fluid into one

Guengerich, Sanders-Bush named ASPET fellows

Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET).

UPDATE: Information about 403(b) Plan Settlement

In late August a number of faculty members and other employees received a notice regarding a class action settlement from the Settlement Administrator that has been appointed in the matter.

Microvilli in motion

Live cell imaging studies have revealed that microvilli — finger-like protrusions on the surface of epithelial cells — move and collide as they form the brush border.

1 18 19 20 21 22 69